Webinar Summary/Description
The astounding rate of monoclonal antibody based-drug development, and the evolution towards next-generation scaffolds and antibody drug conjugates, presents an enormous analytical hurdle due to ever-increasing diversity. Finding the right analytical platform that can help address this challenge, by offering flexible workflows to characterize biomolecules at the intact and peptide level becomes very important. Join us to learn about new portfolio of biopharma tools and workflows being developed to fit any throughput requirement, regardless of the depth of information needed and the level of LC/MS experience of the researcher. Our experts will share their knowledge and expertise around these latest innovations for biopharma to help you tackle the ever-changing challenges in analytical characterization.
For Research Use Only. Not for use in diagnostic procedures.
In this webinar you will learn about:
- How to characterize intact mAbs and peptides using the new 6545XT AdvanceBio LC/Q-TOF
- How to assess molecular weight, degree of heterogeneity, post-translation modifications, sequence variations, degradation products and more
- Factors to consider for good characterization of mAbs: accuracy, reproducibility, resolution, precision, dynamic range, throughput, time for analysis, streamlined workflow and automation
- Overcoming current bottlenecks: from sample preparation to data processing and interpretation
Who should attend:
- Analytical Chemists
- Process Chemists
- Screening Experts
- Biopharma scientists